Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Transillumination (TL) is a noninvasive technique that appears to allow preliminary detection of superficial vascular structures of the face to avoid intravascular HA injection. The purpose of our study was to test the efficacy of TL in terms of its sensitivity to locate vessels in the areas undergoing treatment and to reduce post-injection vascular complications.
Transillumination was used during the injection of hyaluronic acid to reduce the risk of intravascular injection. For the purpose of randomization, patients were asked to choose a sealed envelope. Inside the envelope was a piece of paper indicating on which side of the face (right or left) the transillumination would be used.
For each filler injection, transillumination was used on one side; on the other side of the face, the injection was administered without the use of any vascular exploration method. After the vessels had been located on the side chosen for the transillumination technique, a skin-marker pencil was used to draw the vascular mapping of the upper part of the face, which in our opinion represented the area most at risk of complications, the middle and the lower parts of the face.
Then ice was applied on both sides of the face for 15 s before to proceed with the injections in order to cause vasoconstriction and to further decrease the risk of an intravascular injection.Transillumination sensitivity for locating the vessels of the face was assessed.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Transillumination Venolux® | Experimental | Transillumination using Venolux was used to visualize veins in the hemiface before hyaluronic acid injections |
|
| Comparator group | No Intervention | No vascular exploration methods were used on the other hemiface |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Transillumination Venolux® | Device | Transillumination Venolux® method was used on the other half of the face before injections to visualize veins. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of vessels detected by using transillumination | counting the number of vessels detected by using transillumination in relation to the number of existing vessels. | Before facial injections |
| Measure | Description | Time Frame |
|---|---|---|
| Number of bruises and hematoma | Number of bruises and heamatoma post-injection in in the hemiface where Transillumination is used versus control hemiface | At day 3 after facial injections |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jean Meningaud, MD.PhD | Department of plastic and reconstructive surgery-Henri Mondor Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| MEZI | Créteil | 94000 | France |
Not provided
The random assignment of the right or left side of the face on which the trasnillumination will be used will be done by numbered and sealed envelope.
Envelopes will be prepared before the start of inclusion. Each envelope will contain a sheet of paper whose contents cannot be guessed when the envelope is closed. Each sheet will be marked either "Left+TL" or "Right+TL". Each envelope will contain a unique code number that will be randomly assigned to each patient after inclusion.
Not provided
Not provided
The operator will guarantee the confidentiality of the part of facial where the trasillumination was used, the assessors will not be aware of the part of the face where the transillumination was used.